NCT00345059 The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT00338039 Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients Status COMPLETED Phase PHASE2
NCT00336700 A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00334802 Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00330746 CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00327327 Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT00326911 Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00325234 Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00323869 Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00320749 Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer Status COMPLETED Phase PHASE1
NCT00320541 A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00316420 Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00316199 Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00312988 Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy Status COMPLETED Phase PHASE3
NCT00307723 Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00301301 A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) Status COMPLETED Phase N/A
NCT00300950 Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer Status COMPLETED Phase PHASE2
NCT00300586 IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3